HISA has to get its annual budget approved by the Federal Trade Commission each year, and often releases that total to the ...

To overcome these limitations, Antengene developed ATG-201, a "2+1" CD19 x CD3 TCE, which was evaluated in a series of in vitro studies for binding affinity, T cell dependent cytotoxicity (TDCC) ...